Prevest Denpro Ltd.

View in App
437.00 -2.65 ▼-0.6%

29 May 2023, 10:27:00 AM
Volume: 8,400

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.prevestdenpro.com
Market Cap 527.71 Cr.
Enterprise Value(EV) 527.71 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 13.09 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 33.59 Trailing Twelve Months Ending 2023-03
Industry PE 53.45 Trailing Twelve Months Ending 2023-03
Book Value / Share 60.65 Trailing Twelve Months Ending 2023-03
Price to Book Value 7.25 Calculated using Price: 439.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.20 Cr. 12,003,000 Shares
FaceValue 10
About Prevest Denpro Ltd.
The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Prevest Denpro Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Prevest Denpro Ltd. Performance

View details >>
1 Day
-0.60%
1 Week
+4.37%
1 Month
+8.22%
3 Month
+34.79%
6 Month
+11.97%
1 Year
+33.29%
2 Year
5 Year
10 Year

Prevest Denpro Ltd. Fundamental Ratios

View details >>
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 29.72 34.02 39.13 38.13 29.07
Return on Capital Employed (%) 37.15 39.27 45.63 46.96 39.64
Return on Assets (%) 18.88 22.30 27.50 27.85 24.40

Prevest Denpro Ltd. Balance Sheet

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 7 10 15 23 57 73
Non Curr. Liab. 1 2 2 2 2 0
Curr. Liab. 3 3 4 7 5 5
Minority Int.
Equity & Liab. 12 15 21 31 64 79
Non Curr. Assets 4 5 6 7 11 24
Curr. Assets 7 10 16 24 53 54
Misc. Exp. not W/O
Total Assets 12 15 21 31 64 79

Prevest Denpro Ltd. Profit and Loss

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 17 19 23 28 38 50
Other Income 1 0 2 1 2 2
Total Income 18 20 25 30 40 52
Total Expenditure -14 -15 -18 -19 -23 -30
PBIDT 4 4 7 10 17 22
Interest 0 0 0 0 0
Depreciation 0 0 0 0 -1 -1
Taxation -1 -1 -1 -2 -4 -5
Exceptional Items
PAT 2 3 5 7 12 16
Adjusted EPS 76 105 176 8 10 13

Prevest Denpro Ltd. Cash Flow

View details >>
Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 3 5 9 7
Cash Fr. Inv. -1 -1 -1 -2 -4
Cash Fr. Finan. 0 0 0 -1 23
Net Change 1 2 4 6 26
Cash & Cash Eqvt 4 6 10 16 42

Prevest Denpro Ltd. Shareholding Pattern

View details >>
6 Qtrs 2021-09 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 73.60 73.60 73.60 73.60 73.60 73.60
Public 26.40 26.40 26.40 26.40 26.40 26.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Prevest Denpro Ltd. Announcements

View details >>
Mon, 22 May 2023
Intimation Of Incorporation Of Subsidiary Company-Denvisio Biomed Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Intimation of incorporation of Subsidiary Company.
Tue, 16 May 2023
Statement Of NIL Deviation Or Variation In The Use Of Proceeds Of Initial Public Offer
Pursuant to the aforesaid SEBI Listing Regulations please find enclosed Statement confirming that there are no deviation(s) or variation(s) in respect of utilization of proceeds of Initial Public Offer of the Company for the quarter ended March 31 2023 as mentioned in the object clause of the offer letter of the issue.
Tue, 16 May 2023
Statement Of NIL Deviation Or Variation In The Use Of Proceeds Of Initial Public Offer
Pursuant to the aforesaid SEBI Listing Regulations please find enclosed Statement confirming that there are no deviation(s) or variation(s) in respect of utilization of proceeds of Initial Public Offer of the Company for the quarter ended December 31 2022 as mentioned in the object clause of the offer letter of the issue.

Prevest Denpro Ltd. Technical Scans

View details >>
Fri, 26 May 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Prevest Denpro Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 955.35 -1.5%
Divi's Laboratories Ltd. 93,212.66 3,483.10 -0.9%
Cipla Ltd. 76,767.04 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.75 +0.0%
Mankind Pharma Ltd. 53,007.87 1,371.50 +3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,483.10 -0.9%
Cipla Ltd. Consolidated 2023-03 27.40 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,371.50 +3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,483.10 -0.9%
Cipla Ltd. Consolidated 2023-03 3.28 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,371.50 +3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,483.10 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,371.50 +3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,483.10 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,371.50 +3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,483.10 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,371.50 +3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,483.10 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,371.50 +3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 955.35 -1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,483.10 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 946.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,558.90 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,588.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.75 +0.0%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,371.50 +3.6%

Prevest Denpro Ltd. FAQ's

What is Prevest Denpro share price?
Can I buy Prevest Denpro shares now?
What is the Market Cap of Prevest Denpro?
What are the key metrics to analyse Prevest Denpro?
What is the 52 Week High and Low of Prevest Denpro?
What is the trend of Prevest Denpro share price?